Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...

Ultraviolet light therapy may help reduce inflammation and disease severity in people with MS, according to data from a small ...

A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on health-related quality of life, with findings that could reshape how services ...

Missing Kansas deer hunter found on river log jam Florida boat builder faces 30 years in prison for ripping off customers in six states Bills' Josh Allen gets telling message from Chiefs coach after ...

Scientists at UCSF have uncovered evidence that multiple sclerosis silently damages the brain years before diagnosis. By studying proteins in blood samples, they identified early immune signals and ...

A new study published in Nature’s Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after ...

Multiple sclerosis (MS) is an autoimmune condition in which the protective insulation surrounding neurons in the brain and spinal cord is erroneously attacked. This can cause a wide variety of serious ...